Literature DB >> 3549894

Human allospecific cytolytic T lymphocyte lysis of a murine cell transfected with HLA-A2.

T D Koller, C Clayberger, J L Maryanski, A M Krensky.   

Abstract

A variety of molecules are involved in the interaction of human allospecific cytolytic T lymphocytes (CTL) with target cells. Monoclonal antibodies specific for these molecules inhibit CTL-target conjugate formation and/or lysis. To further study recognition and lysis of targets by human CTL, we used a murine mastocytoma cell line transfected with the histocompatibility leukocyte antigen (HLA)-A2 gene (P815-A2+) as a target for human HLA-A2-specific CTL. We find that only a subset of human HLA-A2-specific CTL can lyse murine P815-A2+ cells, suggesting that the murine cells may lack one or more accessory molecules needed for CTL recognition and lysis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549894

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Target-cell contact activates a highly selective capacitative calcium entry pathway in cytotoxic T lymphocytes.

Authors:  A Zweifach
Journal:  J Cell Biol       Date:  2000-02-07       Impact factor: 10.539

2.  Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment.

Authors:  G Dadaglio; F Michel; P Langlade-Demoyen; P Sansonetti; D Chevrier; F Vuillier; F Plata; A Hoffenbach
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

3.  Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain.

Authors:  A Wright; J E Lee; M P Link; S D Smith; W Carroll; R Levy; C Clayberger; A M Krensky
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

4.  Cytotoxic T lymphocytes from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells.

Authors:  E J Bernhard; A X Le; J A Barbosa; E Lacy; V H Engelhard
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.